BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38216936)

  • 1. An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
    Gao Y; Wang W; Yang Y; Xu Z; Lin Y; Lang T; Lei S; Xiao Y; Yang W; Huang W; Li Y
    BMC Cancer; 2024 Jan; 24(1):69. PubMed ID: 38216936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study.
    Chang L; Zhang Y; Zhu J; Hu L; Wang X; Zhang H; Gu Q; Chen X; Zhang S; Gao M; Wei X
    Front Endocrinol (Lausanne); 2023; 14():964074. PubMed ID: 36896175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence-based prediction of cervical lymph node metastasis in papillary thyroid cancer with CT.
    Wang C; Yu P; Zhang H; Han X; Song Z; Zheng G; Wang G; Zheng H; Mao N; Song X
    Eur Radiol; 2023 Oct; 33(10):6828-6840. PubMed ID: 37178202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.
    Jin P; Chen J; Dong Y; Zhang C; Chen Y; Zhang C; Qiu F; Zhang C; Huang P
    Front Endocrinol (Lausanne); 2022; 13():993564. PubMed ID: 36060946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics from Primary Tumor on Dual-Energy CT Derived Iodine Maps can Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.
    Zhou Y; Su GY; Hu H; Tao XW; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
    Acad Radiol; 2022 Mar; 29 Suppl 3():S222-S231. PubMed ID: 34366279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
    Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
    Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
    Gao X; Luo W; He L; Cheng J; Yang L
    Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma by CT Radiomics.
    Peng Y; Zhang ZT; Wang TT; Wang Y; Li CH; Zuo MJ; Lin HS; Gong LG
    Acad Radiol; 2023 Jul; 30(7):1400-1407. PubMed ID: 36220726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiomics nomogram for the ultrasound-based evaluation of central cervical lymph node metastasis in papillary thyroid carcinoma.
    Wen Q; Wang Z; Traverso A; Liu Y; Xu R; Feng Y; Qian L
    Front Endocrinol (Lausanne); 2022; 13():1064434. PubMed ID: 36531493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonic Feature Prediction of Large-Number Central Lymph Node Metastasis in Clinically Node-Negative Solitary Papillary Thyroid Carcinoma.
    Xiao W; Hu X; Zhang C; Qin X
    Endocr Res; 2023 Oct; 48(4):112-119. PubMed ID: 37606889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of clinical features combined with multimodal ultrasound in predicting lymph node metastasis in cervical central area of papillary thyroid carcinoma.
    Xue J; Li S; Qu N; Wang G; Chen H; Wu Z; Cao X
    J Clin Ultrasound; 2023 Jun; 51(5):908-918. PubMed ID: 37058552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
    Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G
    Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT Radiomics-Based Nomogram for Predicting the Lateral Neck Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Prospective Multicenter Study.
    Dong L; Han X; Yu P; Zhang W; Wang C; Sun Q; Song F; Zhang H; Zheng G; Mao N; Song X
    Acad Radiol; 2023 Dec; 30(12):3032-3046. PubMed ID: 37210266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating US-guided FNAB, BRAF
    Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shear wave elastography combined with gray-scale ultrasound for predicting central lymph node metastasis of papillary thyroid carcinoma.
    Li T; Li H; Xue J; Miao J; Kang C
    Surg Oncol; 2021 Mar; 36():1-6. PubMed ID: 33271464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F
    Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme gradient boosting model to assess risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual prediction using SHapley Additive exPlanations.
    Zou Y; Shi Y; Sun F; Liu J; Guo Y; Zhang H; Lu X; Gong Y; Xia S
    Comput Methods Programs Biomed; 2022 Oct; 225():107038. PubMed ID: 35930861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
    Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
    Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.